BIO chief Jim Greenwood: FDA should hire a CIO to question drug rejections – Boston Business Journal

The head of the leading biotechnology trade group, the Biotechnology Industry Organization (BIO), was in Boston this week, ahead of the group’s annual meeting, taking place at the Boston Convention and Exhibition Center from June 18 to June 21.

Former U.S. Rep. Jim Greenwood said the trade group is advocating for a “Chief Innovation Officer” to be named at the U.S. Food and Drug Administration, who would examine whether the number of drug rejections is reasonable, or whether it is stunting innovation and causing unwarranted delays.